247 related articles for article (PubMed ID: 26906236)
1. Automated Electrophysiological and Pharmacological Evaluation of Human Pluripotent Stem Cell-Derived Cardiomyocytes.
Rajamohan D; Kalra S; Duc Hoang M; George V; Staniforth A; Russell H; Yang X; Denning C
Stem Cells Dev; 2016 Mar; 25(6):439-52. PubMed ID: 26906236
[TBL] [Abstract][Full Text] [Related]
2. Probing flecainide block of I
Geng L; Kong CW; Wong AOT; Shum AM; Chow MZY; Che H; Zhang C; Yau KL; Chan CW; Keung W; Li RA
Toxicol Lett; 2018 Sep; 294():61-72. PubMed ID: 29758359
[TBL] [Abstract][Full Text] [Related]
3. Automated Dynamic Clamp for Simulation of I
Becker N; Horváth A; De Boer T; Fabbri A; Grad C; Fertig N; George M; Obergrussberger A
Curr Protoc Pharmacol; 2020 Mar; 88(1):e70. PubMed ID: 31868992
[TBL] [Abstract][Full Text] [Related]
4. High-throughput electrophysiological assays for voltage gated ion channels using SyncroPatch 768PE.
Li T; Lu G; Chiang EY; Chernov-Rogan T; Grogan JL; Chen J
PLoS One; 2017; 12(7):e0180154. PubMed ID: 28683073
[TBL] [Abstract][Full Text] [Related]
5. High-Content Electrophysiological Analysis of Human Pluripotent Stem Cell-Derived Cardiomyocytes (hPSC-CMs).
Kong CW; Geng L; Li RA
Methods Mol Biol; 2018; 1722():185-194. PubMed ID: 29264806
[TBL] [Abstract][Full Text] [Related]
6. Recording of multiple ion current components and action potentials in human induced pluripotent stem cell-derived cardiomyocytes via automated patch-clamp.
Mann SA; Heide J; Knott T; Airini R; Epureanu FB; Deftu AF; Deftu AT; Radu BM; Amuzescu B
J Pharmacol Toxicol Methods; 2019; 100():106599. PubMed ID: 31228558
[TBL] [Abstract][Full Text] [Related]
7. High purity human-induced pluripotent stem cell-derived cardiomyocytes: electrophysiological properties of action potentials and ionic currents.
Ma J; Guo L; Fiene SJ; Anson BD; Thomson JA; Kamp TJ; Kolaja KL; Swanson BJ; January CT
Am J Physiol Heart Circ Physiol; 2011 Nov; 301(5):H2006-17. PubMed ID: 21890694
[TBL] [Abstract][Full Text] [Related]
8. Novel screening techniques for ion channel targeting drugs.
Obergrussberger A; Stölzle-Feix S; Becker N; Brüggemann A; Fertig N; Möller C
Channels (Austin); 2015; 9(6):367-75. PubMed ID: 26556400
[TBL] [Abstract][Full Text] [Related]
9. Action potential characterization of human induced pluripotent stem cell-derived cardiomyocytes using automated patch-clamp technology.
Scheel O; Frech S; Amuzescu B; Eisfeld J; Lin KH; Knott T
Assay Drug Dev Technol; 2014 Oct; 12(8):457-69. PubMed ID: 25353059
[TBL] [Abstract][Full Text] [Related]
10. Minimized cell usage for stem cell-derived and primary cells on an automated patch clamp system.
Becker N; Stoelzle S; Göpel S; Guinot D; Mumm P; Haarmann C; Malan D; Bohlen H; Kossolov E; Kettenhofen R; George M; Fertig N; Brüggemann A
J Pharmacol Toxicol Methods; 2013; 68(1):82-7. PubMed ID: 23567076
[TBL] [Abstract][Full Text] [Related]
11. Functional Impact of BeKm-1, a High-Affinity hERG Blocker, on Cardiomyocytes Derived from Human-Induced Pluripotent Stem Cells.
De Waard S; Montnach J; Ribeiro B; Nicolas S; Forest V; Charpentier F; Mangoni ME; Gaborit N; Ronjat M; Loussouarn G; Lemarchand P; De Waard M
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32998413
[TBL] [Abstract][Full Text] [Related]
12. Chemical-defined and albumin-free generation of human atrial and ventricular myocytes from human pluripotent stem cells.
Pei F; Jiang J; Bai S; Cao H; Tian L; Zhao Y; Yang C; Dong H; Ma Y
Stem Cell Res; 2017 Mar; 19():94-103. PubMed ID: 28110125
[TBL] [Abstract][Full Text] [Related]
13. Dynamic Clamp in Electrophysiological Studies on Stem Cell-Derived Cardiomyocytes-Why and How?
Verkerk AO; Wilders R
J Cardiovasc Pharmacol; 2021 Mar; 77(3):267-279. PubMed ID: 33229908
[TBL] [Abstract][Full Text] [Related]
14. Hydrogen sulfide suppresses outward rectifier potassium currents in human pluripotent stem cell-derived cardiomyocytes.
Wei H; Zhang G; Qiu S; Lu J; Sheng J; Manasi ; Tan G; Wong P; Gan SU; Shim W
PLoS One; 2012; 7(11):e50641. PubMed ID: 23226343
[TBL] [Abstract][Full Text] [Related]
15. Utilising Automated Electrophysiological Platforms in Epilepsy Research.
Milligan CJ; Pachernegg S
Methods Mol Biol; 2021; 2188():133-155. PubMed ID: 33119850
[TBL] [Abstract][Full Text] [Related]
16. Repolarization reserve determines drug responses in human pluripotent stem cell derived cardiomyocytes.
Braam SR; Tertoolen L; Casini S; Matsa E; Lu HR; Teisman A; Passier R; Denning C; Gallacher DJ; Towart R; Mummery CL
Stem Cell Res; 2013 Jan; 10(1):48-56. PubMed ID: 23089628
[TBL] [Abstract][Full Text] [Related]
17. Human-induced pluripotent stem cell-derived cardiomyocytes from cardiac progenitor cells: effects of selective ion channel blockade.
Altomare C; Pianezzi E; Cervio E; Bolis S; Biemmi V; Benzoni P; Camici GG; Moccetti T; Barile L; Vassalli G
Europace; 2016 Dec; 18(suppl 4):iv67-iv76. PubMed ID: 28011833
[TBL] [Abstract][Full Text] [Related]
18. Electrophysiological Analysis of human Pluripotent Stem Cell-derived Cardiomyocytes (hPSC-CMs) Using Multi-electrode Arrays (MEAs).
Sala L; Ward-van Oostwaard D; Tertoolen LGJ; Mummery CL; Bellin M
J Vis Exp; 2017 May; (123):. PubMed ID: 28570546
[TBL] [Abstract][Full Text] [Related]
19. Establishment of an automated patch-clamp platform for electrophysiological and pharmacological evaluation of hiPSC-CMs.
Li W; Luo X; Ulbricht Y; Wagner M; Piorkowski C; El-Armouche A; Guan K
Stem Cell Res; 2019 Dec; 41():101662. PubMed ID: 31809994
[TBL] [Abstract][Full Text] [Related]
20. Phenotype-Based High-Throughput Classification of Long QT Syndrome Subtypes Using Human Induced Pluripotent Stem Cells.
Yoshinaga D; Baba S; Makiyama T; Shibata H; Hirata T; Akagi K; Matsuda K; Kohjitani H; Wuriyanghai Y; Umeda K; Yamamoto Y; Conklin BR; Horie M; Takita J; Heike T
Stem Cell Reports; 2019 Aug; 13(2):394-404. PubMed ID: 31378668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
